Quantcast

Latest Neurodegeneration Stories

2014-04-28 23:13:23

Forum Uniquely Brings Together Leading Family Offices and Their Foundations Seeking Impact Investment, Grant-Giving, and Philanthropy Opportunities within Health and Life Sciences New York, NY (PRWEB) April 28, 2014 FPRT Bio, a clinical stage company developing a novel anti-inflammatory drug therapy for the treatment for neurodegenerative diseases including ALS, Parkinson’s and Alzheimer’s disease, announced today it has been selected to present at the Cavendish Global Health Impact...

2014-04-28 08:33:12

EU support boosts development of therapeutic vaccines against Parkinson's and Multiple System Atrophy. AFFiRiS leads consortium. VIENNA, April 28, 2014 /PRNewswire/ -- An international consortium of top European research teams has received significant EU funding for the development of therapeutic vaccines against Parkinson's Disease (PD) and Multiple System Atrophy (MSA). Led by the Austrian biotech company AFFiRiS AG, the consortium will use a novel tandem strategy to advance...

Genetic Legacy Of A Rare Brain Disorder Traced Back To The Ottoman Empire
2014-04-25 05:17:10

redOrbit Staff & Wire Reports - Your Universe Online Scientists have detected a previously unknown neurodegenerative disorder stemming from a single mutation in one lone individual who lived approximately 16 generations ago during the days of the Ottoman Empire in Turkey, according to two studies appearing in Thursday’s edition of the journal Cell.  [ 1 ] [ 2 ] Two international teams of researchers, each of which was performing DNA sequencing of thousands of Turkish children...

2014-04-24 10:52:56

TAU discovers that protein clusters implicated in neurodegenerative diseases actually serve to protect brain cells People diagnosed with Huntington's disease, most in their mid-thirties and forties, face a devastating prognosis: complete mental, physical, and behavioral decline within two decades. "Mutant" protein clusters, long blamed for the progression of the genetic disease, have been the primary focus of therapies in development by pharmaceutical companies. But according to new...

2014-04-22 12:09:23

Research published in the Journal of Molecular Biology Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases. These molecules are based on what the Company calls a general amyloid interaction motif, or GAIM, which recognizes a characteristic common to many toxic, misfolded proteins, not just...

2014-04-22 08:30:14

--Research Published in the Journal of Molecular Biology-- CAMBRIDGE, Mass., April 22, 2014 /PRNewswire/ -- Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases. These molecules are based on what the Company calls a general amyloid interaction motif, or GAIM, which recognizes a...

2014-04-15 12:30:22

Scientist's 'monumental' discoveries underlie one of the largest fields in modern biomedical research, including efforts to treat cancer and neurodegenerative diseases ALBANY, N.Y., April 15, 2014 /PRNewswire-USNewswire/ ----Alexander Varshavsky, Ph.D., whose landmark discoveries transformed the understanding of how cell behavior impacts diseases including cancer, autoimmune disorders and other illnesses, has been selected to receive the prestigious Albany Medical Center Prize in...

2014-04-14 14:20:45

Alzheimer's disease, the primary cause of dementia in the elderly, imposes a tremendous social and economic burden on modern society. In Japan, the burden of the disease in 2050 is estimated to be a half a trillion US dollars, a figure equivalent to the government's annual revenues. Unfortunately, it has proven very difficult to develop drugs capable of ameliorating the disease. After a tremendous burst of progress in the 1990s, the pace of discoveries has slowed. Dr. Saido believes that...

2014-03-26 12:28:27

Biomedical research institute appoints two key positions, expanding its impact on neurodegenerative science GRAND RAPIDS, Mich., March 26, 2014 /PRNewswire/ -- Van Andel Research Institute's Center for Neurodegenerative Science continues to expand its research portfolio and increase its impact in the field of Parkinson's disease research. The Center recently appointed Dr. Jiyan Ma, whose laboratory studies prions, the misfolded proteins associated with many contagious...

2014-03-25 08:31:05

--Funds Will Advance Novel Approach for Treatment of Alzheimer's Disease and Other Diseases of Protein Aggregation-- CAMBRIDGE, Mass., March 25, 2014 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc. today announced the completion of a $17 million Series D financing from existing and new investors to advance the Company's lead candidate, NPT088, and potential next-generation compounds toward clinical trials. NPT088 has the potential to treat a wide range of neurodegenerative diseases,...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.